Navigation Links
DiObex and Camurus Sign License Agreement for the Development of DIO-901 in FluidCrystal(R) Extended Release Technology
Date:3/18/2008

Development program for prevention of insulin-induced hypoglycemia in

diabetes

SAN FRANCISCO and LUND, Sweden, March 18 /PRNewswire/ -- DiObex and Camurus announced today that they have signed a license agreement to develop DIO-901(very low dose glucagon) in the Camurus drug delivery technology, FluidCrystal(R). The development candidate is an extended release formulation of low dose glucagon for the prevention of insulin-induced hypoglycemia in patients with diabetes.

"Intensive glycemic control is beneficial for patients with diabetes, but it increases their risk of hypoglycemia, which can lead to a spectrum of problems ranging from reduced quality of life to coma and death," said David Cory, DiObex CEO. "This license agreement and development program reflects our commitment to deliver an extended release form of low dose glucagon to the market for the prevention of insulin-induced hypoglycemia."

There is no product approved for the prevention of insulin-induced hypoglycemia in patients with diabetes. DiObex has successfully completed three Phase 1 proof-of-principle studies using very low dose glucagon infusions in type 1 diabetic patients. DIO-901 has received Fast Track status from the FDA for this program. The DIO-901 FluidCrystal(R) extended release formulation is scheduled to enter human clinical trials in the second half of 2008.

"We are very pleased to enter into this license agreement with DiObex and have great hope for the development of DIO-901. The extended release version of DIO-901 using our FluidCrystal(R) delivery technology has the potential to fulfill an important medical need in the treatment of diabetes," said Fredrik Tiberg, President and CEO of Camurus AB.

Terms of the agreement include an undisclosed signing fee, development milestones, future royalties on product sales and a share of any potential DiObex sublicensing revenues.

About DiObex

DiObex, Inc
'/>"/>

SOURCE DiObex, Inc.; Camurus AB
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. DiObex Inc. to Present at BIO Mid-America Venture Forum
2. DiObex, Inc. to Present at Merrill Lynch Global Healthcare Conference
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
5. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
6. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
7. Pharsight Achieves First License Sale for Public-Source Database
8. Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan
9. Niceware International Announces Licensed Vendor Status with ICCBBA, Inc. to Provide ISBT 128-compliant Software
10. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., , CHANGCHUN, China and LOS ANGELES...gxin Pharmaceuticals, Inc. (OTC Bulletin Board: CY...y,), a leading manufacturer, distributor and,retai...y announced it has,completed preparation for distr...,, The Chinese government recently formaliz...
(Date:11/30/2009)..., , NOVATO, Calif., Nov. 30 /PRNewswire-Firs...MRN ) announced today that the Food and Drug Admin...n for 3,4-diaminopyridine (3,4-DAP), amifampridine...t Eaton Myasthenic Syndrome (LEMS). 3,4-DAP has p...E.U. Also, in October 2009, the Committee for Med...
(Date:11/30/2009)..., , SEATTLE, Nov. 30 /PRNewswire-Firs...d MTA: CTIC) announced today that its new class of...latinates, demonstrated a stronger anti-tumor pote...latinum-based compounds as well as the ability to .... The results were presented in a paper titled "N...
(Date:11/30/2009)..., , SHANGHAI, Nov. 30 /PRNewswire-...pharmaceutical, biotechnology, and medical-device ...operations in China and the United States,announc...ology Fast 50 China,2009 list for the fifth consec...wing companies in China,s technology, media, and t...
Breaking Biology Technology:China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2
...w sensor structures that could be used in novel se...r in highly sensitive medical sensors, according t...etters . , The new ,nanosensors, which are based... and US research groups, could be tailor-made to i...es, for example poisons or explosives in transport...
...rstCall/ - EnWave Corporation (TSX-V: ENW) ("EnWav...l completion of tests using its recently developed...es and probiotics from the Danish group Danisco. T...greement signed with Danisco last year. The object...thod delivering high-speed continuous bulk powder ...
...elease is being issued by Council for American Med...m.com/cgi-bin/prnh/20090325/DC89081LOGO ) , , ...of medical science and discovery in the United Sta...to maintaining America,s leadership in medical inn...advocates, biotechnology industry representatives,...
Other Biology Technology:New security and medical sensor devices made possible by metallic nanostructures 2EnWave Announces Collaboration and Initial Testing Results with Danisco AS 2EnWave Announces Collaboration and Initial Testing Results with Danisco AS 3Council for American Medical Innovation Brings U.S. Leaders in Medicine, Biotechnology and Discovery Together in Chicago for 'Best and Brightest Forum on Medical Innovation' 2
(Date:11/24/2009)...protein that may help gut bacteria bind to the gas...probiotic producers to identify strains that are l...ics need to interact with cells lining the gut to ...rfaces in the gut they are more likely to stick ar... Nathalie Juge from the Institute of Food Research...
(Date:11/24/2009)...ber 24, 2009) -- The Wildlife Conservation Society... last remaining population of Siberian tigers has ...de of poaching and habitat loss. , W...als of what needs to be done to protect remaining ... The report was released by the Siberian Tig...
(Date:11/24/2009)...Spanish . , The presence of increased body f...bstances in the blood, hinders the loss and mainte...ct of the University of Navarra conducted by Estba...Pharmacy. , The project, entitled "A nutrigeneti...l of body weight and inflammation," examines how t...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2Report shows dramatic decline in Siberian tigers 2It can be predicted the reaction obese patients will have to a diet 2Antipsychotic Drugs Spur Dramatic Weight Gain in Kids 60185 1Antipsychotic Drugs Spur Dramatic Weight Gain in Kids 60185 2Antipsychotic Drugs Spur Dramatic Weight Gain in Kids 60185 3Antipsychotic Drugs Spur Dramatic Weight Gain in Kids 60185 4More Swine Flu Vaccine Coming Soon 60183 1More Swine Flu Vaccine Coming Soon 60183 2More Swine Flu Vaccine Coming Soon 60183 3Phone Counseling for Depression Rings With Promise 60181 1Phone Counseling for Depression Rings With Promise 60181 2
... Radiological health expert Daniel Hayes, Ph.D., o...l Hygiene suggests that a form of vitamin D could ...ge from low levels of radiation. Writing in the I...ains that calcitriol, the active form of vitamin D...ld be used as a safe protective agent before or af...
..., The answer to successful revegetation of native ...necessarily relying on remnant local native vegeta...local native plants are the best source of seed fo... from CSIRO, Australia,s national science agency. ...ted to local conditions and therefore it would pro...
... AMES, Iowa -- Turtles nesting along the Mississip...g dates in response to rising temperatures, says a...nzen, a professor in ecology, evolution and organi...d also accumulated research going back decades in ...ut when they make nests and lay eggs. , "The resu...
Other Biology News:Could vitamin D save us from radiation? 2Turtles alter nesting dates due to temperature change says ISU researcher 2
SmartScan Solo from ABgene
Fluoroskan Ascent FL, 100-240 V, one dispenser from Thermo Scientific
...yme that catalyzes the conversion,of starch to a m...ns. The level of a-amylase in various fluids of th...plant and microbial,a-amylases are important enzym...E-11954) provides the,speed, high sensitivity and ...
...raeus HERAsafe KS convince with an optimum product... ,The new frameless slanted window does not obscu... design makes it easy to work in a relaxed posture...an 250 mm ensures ease of handling. ,The eye-leve...
Biology Products: